Outcomes were evaluated among children born between April 1980 and June 2019 by using data from 12 observational birth ...

Early results from the phase 1 SANRECO trial suggest that divesiran is safe and well tolerated, and may reduce the need for phlebotomy in patients with polycythemia vera by increasing hepcidin levels ...

While the tax exclusion for employer-sponsored health care was not included in the House-passed reconciliation bill, it ...

A combination of acalabrutinib and venetoclax showed better results with the addition of obinutuzumab, whereas mixed findings ...

Skepticism still persists around the use of measurable residual disease (MRD) for clinical and regulatory decision-making in ...

The Trump administration has ended a program seeking a vaccine for HIV, the first in a series of decisions that is leaving ...

Nonalcoholic fatty liver disease (NAFLD) was linked to elevated liver enzymes in type 2 diabetes mellitus (T2DM) in a recent ...

Sundar Jagannath, MBBS, highlights long-term follow-up data from the phase 1b/2 CARTITUDE-1 trial, showing durable responses and potential cures with ciltacabtagene autoleucel in patients with ...

Bringing this interview with Marla Black Morgan, MD, to a close, she looks to the future of research in both myasthenia ...

Vitiligo Awareness Month and World Vitiligo Day aim to educate the public about the autoimmune skin condition's complex ...

Panelists discuss how autologous stem cell transplant remains essential in frontline multiple myeloma management despite improved quadruple therapy outcomes, emphasizing that current evidence still ...

Panelists discuss how treating obesity as the root cause can create a "virtuous cycle" where weight loss improves insulin resistance, reduces medication needs, and enables better physical activity, ...